Novonesis (Novozymes) B (MEX:NSISN) Margin of Safety % (DCF Earnings Based): -48.00% (As of Jun. 25, 2026)


MEX:NSISN Novonesis (Novozymes) B MEX:NSISN
91 GF Score
Price MXN911.11
GF Value MXN979.45
! 3 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Margin of Safety % (DCF Earnings Based)?

Novonesis (Novozymes) B MEX:NSISN 91 Margin of Safety % (DCF Earnings Based) is -48.00% as of Jun. 25, 2026. GuruFocus rates MEX:NSISN with a GF Score™ of 91/100 and a GF Value™ of MXN979.45. The stock has 3 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-25), Novonesis (Novozymes) B's Predictability Rank is 3-Stars. Novonesis (Novozymes) B's intrinsic value calculated from the Discounted Earnings model is MXN615.61 and current share price is MXN911.11. Consequently,

Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -48.00%.

MEX:NSISN vs LIN, SHW, ECL: Margin of Safety % (DCF Earnings Based) Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B Margin of Safety % (DCF Earnings Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) falls into.


MEX:NSISN
91GF Score
Novonesis (Novozymes) B MEX:NSISN
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Margin of Safety % (DCF Earnings Based) Calculation

Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(615.61-911.11)/615.61
=-48.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of -48.00% mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Margin of Safety % (DCF Earnings Based) of -48.00% as of Jun. 25, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Novonesis (Novozymes) B.
Is Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) too high?
Novonesis (Novozymes) B's current Margin of Safety % (DCF Earnings Based) is -48.00%. Overall, Novonesis (Novozymes) B has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) compare to LIN and SHW?
Novonesis (Novozymes) B's Margin of Safety % (DCF Earnings Based) of -48.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Chemicals company?
A good Margin of Safety % (DCF Earnings Based) depends on the Chemicals industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Novonesis (Novozymes) B. Novonesis (Novozymes) B's current Margin of Safety % (DCF Earnings Based) is -48.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Margin of Safety % (DCF Earnings Based) of -48.00%. The stock's GF Value™ is MXN979.45, compared to a current price of MXN911.11 — trading 7% below its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is -48.00%. Novonesis (Novozymes) B's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Margin of Safety % (DCF Earnings Based) is -48.00% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of MXN911.11 is trading 7% below its estimated GF Value™ of MXN979.45.

Key valuation signals for MEX:NSISN:

  • Margin of Safety % (DCF Earnings Based): -48.00%
  • GF Value™: MXN979.45 vs. price of MXN911.11 (7% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
91GF Score

Get the complete analysis for MEX:NSISN

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN911.11
Price
MXN979.45
GF Value